Biomedicines,
Год журнала:
2023,
Номер
11(10), С. 2760 - 2760
Опубликована: Окт. 12, 2023
MicroRNAs
(miRNAs)
are
promising
biomarkers
in
multiple
sclerosis
(MS).
This
study
aims
to
investigate
the
association
between
a
preselected
list
of
miRNAs
serum
with
therapeutic
response
Glatiramer
Acetate
(GA)
and
clinical
evolution
cohort
relapsing–remitting
MS
(RRMS)
patients.
We
conducted
longitudinal
for
5
years,
cut-off
points
at
2
including
26
RRMS
patients
treated
GA
least
6
months.
A
total
from
previous
(miR-9.5p,
miR-126.3p,
mir-138.5p,
miR-146a.5p,
miR-200c.3p,
miR-223.3p)
were
selected
this
analysis.
Clinical
relapse,
MRI
activity,
confirmed
disability
progression
(CDP),
alone
or
combination
(No
Evidence
Disease
Activity-3)
(NEDA-3),
Expanded
Disability
Status
Scale
(EDSS),
studied.
After
multivariate
regression
analysis,
miR-9.5p
was
associated
EDSS
years
(β
=
0.23;
95%
CI:
0.04–0.46;
p
0.047).
Besides
this,
mean
miR-138.5p
values
lower
those
NEDA-3
(p
0.033),
miR-146a.5p
miR-126.3p
higher
CDP
0.044
0.05
respectively.
These
results
reinforce
use
microRNAs
as
potential
sclerosis.
will
need
more
studies
corroborate
these
data
better
understand
role
pathophysiology
disease.
Neural Regeneration Research,
Год журнала:
2019,
Номер
15(4), С. 606 - 606
Опубликована: Окт. 18, 2019
Multiple
sclerosis
is
a
chronic
autoimmune
disease
of
the
central
nervous
system.
It
main
cause
non-traumatic
neurological
disability
in
young
adults.
mostly
affects
people
aged
20-50
years;
however,
it
can
occur
children
and
much
older
Factors
identified
distribution
MS
include
age,
gender,
genetics,
environment,
ethnic
background.
usually
associated
with
progressive
degrees
disability.
The
involves
demyelination
axons
system
causes
brain
spinal
cord
neuronal
loss
atrophy.
Diagnosing
multiple
based
on
patient's
medical
history
including
symptoms,
physical
examination,
various
tests
such
as
magnetic
resonance
imaging,
cerebrospinal
fluid
blood
tests,
electrophysiology.
course
not
well
correlated
biomarkers
presently
used
clinical
practice.
Blood-derived
that
detect
distinguish
different
phenotypes
may
be
advantageous
personalized
treatment
disease-modifying
drugs
to
predict
response
treatment.
studies
reviewed
have
shown
expression
levels
large
number
miRNAs
peripheral
blood,
serum,
exosomes
isolated
from
are
altered
each
other.
Further
warranted
independently
validate
these
findings
so
individual
or
pairs
serum
potential
diagnostic
markers
for
adult
pediatric
monitoring
progression
therapy.
International Journal of Molecular Sciences,
Год журнала:
2021,
Номер
22(9), С. 4332 - 4332
Опубликована: Апрель 21, 2021
Multiple
sclerosis
(MS)
is
a
chronic,
immune-mediated
disease
and
the
leading
cause
of
disability
among
young
adults.
MicroRNAs
(miRNAs)
are
involved
in
post-transcriptional
regulation
gene
expression.
Of
them,
miR-155
crucial
regulator
inflammation
plays
role
modulating
autoimmune
response
MS.
blood-brain
barrier
(BBB)
disruption
via
down-regulation
key
junctional
proteins
under
inflammatory
conditions.
It
drives
demyelination
processes
by
contributing
to,
e.g.,
microglial
activation,
polarization
astrocytes,
CD47
protein
affecting
transcription
factors.
has
huge
impact
on
development
neuropathic
pain
indirectly
influences
regulatory
T
(Treg)
cell
differentiation
alleviation
hypersensitivity.
This
review
also
focused
neuropsychiatric
symptoms
appearing
as
result
disease-associated
stressors,
brain
atrophy,
pro-inflammatory
Recent
studies
revealed
regulating
anxiety,
stress,
hippocampus,
treatment-resistant
depression.
Inhibition
expression
was
demonstrated
to
be
effective
preventing
pathophysiology
aimed
support
better
understanding
great
dysregulation
various
aspects
MS
highlight
future
perspectives
for
this
molecule.
Frontiers in Cell and Developmental Biology,
Год журнала:
2021,
Номер
8
Опубликована: Янв. 21, 2021
Extracellular
vesicles
(EVs)
are
a
heterogenous
group
of
membrane-bound
particles
that
play
pivotal
role
in
cell–cell
communication,
not
only
participating
many
physiological
processes,
but
also
contributing
to
the
pathogenesis
several
diseases.
The
term
EVs
defines
and
different
based
on
their
biogenesis
release
pathway,
including
exosomes,
microvesicles
(MVs),
apoptotic
bodies.
However,
classification,
biological
function
as
well
protocols
for
isolation
detection
still
under
investigation.
Recent
evidences
suggest
existence
novel
subpopulations
EVs,
increasing
degree
heterogeneity
between
EV
types
subtypes.
have
been
shown
roles
CNS
biomarkers
vehicles
drugs
other
therapeutic
molecules.
They
known
cross
blood
brain
barrier,
allowing
be
detectable
peripheral
fluids,
cargo
may
give
information
parental
cells
pathological
process
they
involved
in.
In
this
review,
we
summarize
knowledge
multiple
sclerosis
(MS)
discuss
recent
potential
applications
diagnostic
targets.
Fluids and Barriers of the CNS,
Год журнала:
2022,
Номер
19(1)
Опубликована: Фев. 8, 2022
Abstract
Background
Multiple
sclerosis
(MS)
is
a
complex,
heterogenous
disease
characterized
by
inflammation,
demyelination,
and
blood–brain
barrier
(BBB)
permeability.
Currently,
active
determined
physician
confirmed
relapse
or
detection
of
contrast
enhancing
lesions
via
MRI
indicative
BBB
However,
clinical
confirmation
can
be
cumbersome.
As
such,
monitoring
in
MS
could
benefit
from
identification
an
easily
accessible
biomarker
disease.
We
believe
extracellular
vesicles
(EV)
isolated
plasma
are
excellent
candidates
to
fulfill
this
need.
Because
the
critical
role
permeability
plays
pathogenesis
disease,
we
sought
identify
EV
originating
central
nervous
system
(CNS)
endothelial
as
biomarkers
MS.
cells
secrete
more
when
stimulated
injured,
hypothesized
that
circulating
concentrations
CNS
derived
will
increased
patients
with
Methods
To
test
this,
developed
novel
method
patient
using
flow
cytometry.
Endothelial
were
identified
absence
lymphocyte
platelet
markers
CD3
CD41,
respectively,
positive
expression
pan-endothelial
CD31,
CD105,
CD144.
determine
if
originated
cells,
expressing
CD144
evaluated
for
myelin
protein
MAL,
specifically
expressed
compared
peripheral
organs.
Results
Quality
control
experiments
indicate
detected
our
cytometry
0.2
1
micron
size.
Flow
analysis
20
healthy
controls,
16
relapsing–remitting
(RRMS)
not
receiving
modifying
therapy,
14
RRMS
stable
17
relapsing-RRMS
natalizumab,
ocrelizumab
revealed
significant
increase
concentration
all
other
groups
(
p
=
0.001).
Conclusions:
For
first
time,
have
circulation
human
blood
samples.
pilot
study
levels
may
Clinical Epigenetics,
Год журнала:
2018,
Номер
10(1)
Опубликована: Ноя. 29, 2018
Multiple
sclerosis
(MS),
a
chronic
inflammatory
demyelinating
disease
of
the
central
nervous
system,
is
characterized
by
axonal
degeneration
and
gliosis.
Although
causes
MS
remain
unknown,
gene
dysregulation
in
system
has
been
associated
with
pathogenesis.
As
such,
various
regulators
expression
may
be
contributing
factors.
The
noncoding
(nc)
RNAs
have
piqued
interest
researchers
due
to
their
known
functions
human
physiology
pathological
processes,
despite
being
generally
as
transcripts
without
apparent
protein-coding
capacity.
Accumulating
evidence
indicated
that
ncRNAs
participate
regulation
acting
epigenetic
factors,
especially
long
(l)
micro
(mi)
RNAs,
they
are
now
recognized
key
regulatory
molecules
MS.
In
this
review,
we
summarize
most
current
studies
on
contribution
pathogenic
processes
discuss
potential
applications
diagnosis
treatment
Journal of Cellular and Molecular Medicine,
Год журнала:
2019,
Номер
23(10), С. 7021 - 7028
Опубликована: Авг. 20, 2019
Abstract
Depression
is
the
most
frequent
psychiatric
disorder
in
world.
Recent
evidence
has
shown
that
stress‐induced
GABAergic
dysfunction
nucleus
accumbens
(NAc)
contributed
to
pathophysiology
of
depression.
However,
molecular
mechanisms
underlying
these
pathological
changes
remain
unclear.
In
this
study,
mice
were
constantly
treated
with
chronic
unpredictable
mild
stress
(CUMS)
till
showing
depression‐like
behaviours
expression.
GABA
synthesis,
release
and
uptake
NAc
tissue
assessed
by
analysing
expression
level
genes
proteins
Gad‐1,
VGAT
GAT‐3
qRT‐PCR
Western
blotting.
The
miRNA/mRNA
network
regulating
was
constructed
based
on
bioinformatics
prediction
software
further
validated
dual‐luciferase
reporter
assay
vitro
vivo,
respectively.
Our
results
showed
GAT‐3,
Gad‐1
mRNA
protein
significantly
decreased
from
CUMS‐induced
than
control
mice.
miRNA‐144‐3p,
miRNA‐879‐5p,
miR‐15b‐5p
miRNA‐582‐5p
directly
down‐regulated
increased.
mRNA/miRNA
regulatory
network,
regulated
binding
seed
sequence
miR‐144‐3p,
miR‐15b‐5p,
miR‐879‐5p
could
be
served
negative
post‐regulators
different
sites
3′‐UTR.
Chronic
causes
impaired
up‐regulating
miRNAs
down‐regulating
mRNAs
proteins,
which
may
reveal
for
concentrations
Journal of Central Nervous System Disease,
Год журнала:
2020,
Номер
12, С. 117957351989495 - 117957351989495
Опубликована: Янв. 1, 2020
Multiple
sclerosis
(MS)
is
a
complex
neurological
disorder
characterized
by
an
aberrant
immune
system
that
affects
patients’
quality
of
life.
Several
environmental
factors
have
previously
been
proposed
to
associate
with
MS
pathophysiology,
including
vitamin
D
deficiency,
Epstein-Barr
virus
(EBV)
infection,
and
cigarette
smoking.
These
may
influence
cellular
molecularity,
interfering
proliferation,
differentiation,
apoptosis.
This
review
argues
small
noncoding
RNA
named
microRNA
(miRNA)
influences
these
factors’
mode
action.
Dysregulation
in
the
miRNAs
network
deeply
impact
hemostasis,
thereby
possibly
resulting
pathogenicity.
article
represents
literature
author’s
theory
how
induce
dysregulations
network,
which
could
ultimately
affect